| Dr Reddys Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 500124 |
NSE Symbol : DRREDDY |
P/E(TTM) : 23.29 |
|
ISIN Demat : INE089A01031 |
Div & Yield% : 0.60 |
EPS(TTM) : 57.64 |
|
Book Value(₹) : 322.48 |
Market Cap(₹Cr) : 112,015.49 |
Face Value(₹) : 1.00 |
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|
| Gross Sales | 6,678.80 | 5,823.90 | 5,081.80 | 4,083.10 | 4,819.10 | 5,420.10 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 6,678.80 | 5,823.90 | 5,081.80 | 4,083.10 | 4,819.10 | 5,420.10 |
| Other Operating Income | 17.50 | 17.30 | 23.00 | 19.90 | 19.60 | 17.20 |
| Other Income | 207.60 | 217.80 | 212.70 | 227.60 | 223.10 | 233.60 |
| Total Income | 6,903.90 | 6,059.00 | 5,317.50 | 4,330.60 | 5,061.80 | 5,670.90 |
| Total Expenditure | 3,974.70 | 3,888.20 | 3,726.20 | 3,446.70 | 3,209.60 | 3,209.60 |
| PBIDT | 2,929.20 | 2,170.80 | 1,591.30 | 883.90 | 1,852.20 | 2,461.30 |
| Interest | 28.40 | 7.10 | 5.90 | 5.60 | 5.80 | 4.50 |
| PBDT | 2,900.80 | 2,163.70 | 1,585.40 | 878.30 | 1,846.40 | 2,456.80 |
| Depreciation | 260.00 | 249.80 | 246.20 | 246.40 | 245.80 | 237.20 |
| Tax | 703.30 | 466.60 | 270.20 | 156.90 | 396.00 | 538.70 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 55.40 | 30.10 | 34.20 | -0.20 | 12.00 | 41.50 |
| Reported Profit After Tax | 1,882.10 | 1,417.20 | 1,034.80 | 475.20 | 1,192.60 | 1,639.40 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 1,882.10 | 1,417.20 | 1,034.80 | 475.20 | 1,192.60 | 1,639.40 |
| EPS (Unit Curr.) | 113.00 | 85.10 | 62.14 | 28.55 | 71.68 | 98.66 |
| EPS (Adj) (Unit Curr.) | 22.60 | 17.02 | 12.43 | 5.71 | 14.34 | 19.73 |
| Calculated EPS (Unit Curr.) | 112.84 | 84.96 | 62.04 | 28.49 | 71.50 | 98.40 |
| Calculated EPS (Adj) (Unit Curr.) | 22.57 | 16.99 | 12.41 | 5.70 | 14.30 | 19.68 |
| Calculated EPS (Ann.) (Unit Curr.) | 451.34 | 339.86 | 248.15 | 113.96 | 286.00 | 393.61 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 90.27 | 67.97 | 49.63 | 22.79 | 57.20 | 78.72 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 83.40 | 83.40 | 83.40 | 83.40 | 83.40 | 83.30 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 43.86 | 37.27 | 31.31 | 21.65 | 38.43 | 45.41 |
| PBDTM(%) | 43.43 | 37.15 | 31.20 | 21.51 | 38.31 | 45.33 |
| PATM(%) | 28.18 | 24.33 | 20.36 | 11.64 | 24.75 | 30.25 |